Ei­sai to ask Aus­tralia to re­con­sid­er re­jec­tion of Alzheimer's drug Leqem­bi

Aus­tralia’s reg­u­la­to­ry agency re­ject­ed Bio­gen and Ei­sai’s Alzheimer’s drug Leqem­bi, not­ing that the drug’s ef­fi­ca­cy doesn’t out­weigh the safe­ty risks.

Aus­tralia’s Ther­a­peu­tic Goods Ad­min­is­tra­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER